This Article Full Text Full Text (PDF) All Versions of this Article: 21/7/1617    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dong, S. Articles by Takahara, H. Search for Related Content PubMed PubMed Citation Articles by Dong, S. Articles by Takahara, H.

Estrogen-Enhanced Peptidylarginine Deiminase Type IV Gene (PADI4) Expression in MCF-7 Cells Is Mediated by Estrogen Receptor--Promoted Transfactors Activator Protein-1, Nuclear Factor-Y, and Sp1

Department of Applied Biological Resource Sciences (S.D., H.T.), School of Agriculture, Ibaraki University, Ami-machi, Inashiki-gun, Ibaraki 300-0393, Japan; and Research Institute for Cell Engineering (Z.Z.), National Institute of Advanced Industrial Science and Technology, Tsukuba, Ibaraki 305-8566, Japan

Address all correspondence and requests for reprints to: Hidenari Takahara, Ph.D., Department of Applied Biological Resource Sciences, School of Agriculture, Ibaraki University, Ami-machi, Inashiki-gun, Ibaraki 300-0393, Japan. E-mail: takahara{at}mx.ibaraki.ac.jp.

Human peptidylarginine deiminase type IV (PAD4), a Ca²⁺-dependent enzyme known to convert arginine residues to citrulline residues in histones, has been shown to be associated with the development of rheumatoid arthritis. Recently, it was noted that the human peptidylarginine deiminase type IV gene (PADI4) regulates the expression of estrogen-responsive genes by modifying the methylated arginine sites in histones H3 and H4. In this study, we demonstrated that PADI4 was expressed in MCF-7 cells and was responsive to estrogen at the transcriptional level. Using the luciferase reporter gene fused to wild-type or mutated 5'-flanking region of PADI4, we characterized that as few as 348 bp upstream from the transcription initiation site were sufficient to direct transcription of the reporter gene. Chromatin immunoprecipitation and small interfering RNA assays revealed that activator protein–1, Sp1/Sp3, and nuclear factor–Y were cis-acting factors bound to the minimal promoter of PADI4 and that they regulated gene expression in a cooperative manner. Moreover, it was indicated that estrogen stimulated PADI4 expression through binding of estrogen receptor (ER)- to the upstream of the PADI4 gene and ER-mediated enhancement of activator protein-1, Sp1, and nuclear factor-Y levels. These findings indicated that estrogen stimulated PADI4 expression through both of the classical and nonclassical ER-mediated pathways.

NURSA Molecule Pages Link:

Nuclear Receptors:   ERα

Ligands:   17β-Estradiol  |  Fulvestrant

This article has been cited by other articles:

				S. Safe and K. Kim Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways J. Mol. Endocrinol., November 1, 2008; 41(5): 263 - 275. [Abstract] [Full Text] [PDF]

				P. Li, H. Yao, Z. Zhang, M. Li, Y. Luo, P. R. Thompson, D. S. Gilmour, and Y. Wang Regulation of p53 Target Gene Expression by Peptidylarginine Deiminase 4 Mol. Cell. Biol., August 1, 2008; 28(15): 4745 - 4758. [Abstract] [Full Text] [PDF]